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. Also, compound heterozygous STAC3 variants, (c.862A>T;p.Lys288* and c.432 + 4A>T), were recently reported in an individual with NAM of Turkish descent (Grzybowski et al., 2017) . NAM is an autosomal recessive condition characterized by congenital weakness, hypotonia, myopathic facies, ptosis, cleft palate, short stature, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH) provoked by anesthesia (Horstick et al., 2013; Stamm DS, Powell, et al., 2008) . Moebius syndrome (MBS) (MIM 157900) and Carey-Fineman-Ziter syndrome (CFZS) (MIM 254940) are congenital syndromes presenting predominantly with characteristic facial weakness. MBS is defined clinically as the presence of congenital, nonprogressive facial weakness with limited abduction of one or both eyes (Miller, 2007; Rucker et al., 2014; Webb et al., 2012 ).
An additional criteria of full vertical motility has also been proposed (MacKinnon et al., 2014) . De novo rare variants in PLXND1 and REV3L were suggested to cause a variety of phenotypes including MBS, congenital facial weakness disorders, and congenital fibrosis of the extraocular muscles in a limited number of cases (Tomas-Roca et al., 2015) . The first case report of autosomal recessive CFZS was in two affected siblings with marked bilateral facial weakness, mild limitation of horizontal gaze, Pierre Robin sequence, hypotonia with generalized muscle hypoplasia, scoliosis, delayed motor milestones, failure to thrive, and normal intelligence (Carey, 2004; Carey, Fineman, & Ziter, 1982) . Additional cases have subsequently been reported with the suggested diagnoses of CFZS (Baraitser & Reardon, 1994; Carey, 2004; Maheshwari et al., 2004; Ryan, Marshall, & FitzPatrick, 1999; Schimke, Collins, & Hiebert, 1993; Verloes et al., 2004) . The molecular etiology of CFZS has not yet been determined, and the clinical spectrum of this disorder will likely be better elucidated after identification of the causative gene. Here we report two sets of sibling pairs, one from Qatari and one from Puerto Rican ancestry, presenting with suspected clinical diagnoses of CFZS or MBS, who were diagnosed with NAM using whole exome sequencing (WES).
| CLINICAL REPORT
The proband in Family 1 (Figures 1 and 3a) was an 8-year-old female who had been diagnosed clinically with CFZS and who presented for a genetic evaluation prior to a planned scoliosis surgery. Her older sister carried the same diagnosis and had a history of MH during a prior scoliosis surgery (Figure 3a) . The sisters shared features of growth delay, cleft palate, kyphoscoliosis, hypotonia, ptosis, and myopathic facies. The proband was born to a G5P4 36-year-old mother via vaginal delivery at full term but small for gestational age (<2 kg). Cleft palate, hypotonia, and limited body movement were noted at birth, and she also required syringe feeding. She had early gross and fine motor delays, which were attributed to weakness and hypotonia. Due to her cleft palate and hypotonia she had speech delay and swallowing difficulties, but no overt cognitive deficits. She was fluent in three languages, comprehensible over 90% of the time, and able to participate in low to moderate intensity age-appropriate physical activity. She tolerated the surgical closure of her palate and dental procedures with general anesthesia.
On exam, at 8 years of age, she was symmetrically small for age with height and weight at the 50th centile for 4-1/2-year-old female and head circumference at −2SD for age. She had a long face with dolichocephaly and downslanting palpebral fissures with severe ptosis.
The mouth was held in an open position with a tented upper lip, downturned corners of the mouth and a surgically intact palate. There was pectus excavatum, short trunk and S-shaped scoliosis of the thoracic and lumbar regions with asymmetric hip position while standing. There were decreased skin creases over distal interphalangeal joints (DIPs), wrists, palms, and plantar surface of feet, likely due to decreased fetal movements (Figure 1 ). Her neurologic exam was significant for axial and appendicular hypotonia plus mild weakness (4/5) of the upper and lower extremities throughout. There was bilateral ptosis and limited ability to raise the lids or furrow the brow, The proband's 18-year-old sister was not available for clinical evaluation, but medical history was provided by her father and by review of medical records. She was the couple's first child and was born with hypotonia, cleft palate, and ptosis. Over time she demonstrated poor growth and hearing loss that was treated with hearing aids, but normal cognition. Her abnormal eye/lid movement and facial diplegia was initially diagnosed as MBS and subsequently, she was given the diagnosis of CFZS. Severe scoliosis and kyphoscoliosis evolved over her early teens. When undergoing anesthesia induction with inhaled agents for spine surgery at 15 years of age, she experienced body stiffening that was considered malignant hyperthermia which was treated in the OR. The surgery proceeded and was uneventful until an episode of prolonged hypotension due to blood loss at the end of the procedure. She was in a coma for 15 days and sustained severe neurologic injury including loss of ambulation and expressive language.
After intensive and prolonged therapy, she walked with assistive equipment, though was largely wheelchair bound and had some verbal communication which was difficult to understand.
The proband in Family 2 (Figures 2a-d and 3b ) is a 21-year-old male who presented with a possible diagnosis of MBS. He was the first child of non-consanguineous Puerto Rican parents. His mother and father were 27 and 26 years old, respectively, at the time of conception. The pregnancy was conceived naturally, and the mother received routine prenatal care and denied prenatal exposures to infections, medications, and drugs. The proband was born via Cesarean section at 36 weeks of gestation due to a nuchal cord. Birth weight was 2.637 kg. At delivery, facial weakness, ptosis, hypotonia, cleft palate, weak cry, and respiratory distress were noticed. The proband was Past medical history was notable for conductive hearing loss diagnosed at age 7 years; he wears hearing aids. Pulmonary function tests revealed respiratory insufficiency. Past surgical history was notable for a first episode of MH at 9 months of age during the first attempt of cleft palate correction. Cleft palate repair and bilateral tympanostomy tube placement was completed at age 4 years without complications. At age 7 years bilateral tympanostomy tubes were placed again without complications. Posterior spinal fusion for scoliosis was completed at age 12 years, which was complicated by a second episode of MH. During this hospitalization, a tracheostomy was placed and was removed after 3 months. Early motor milestones were delayed.
Intelligence was normal. He is currently attending college.
On exam, at 21 years 4 months, weight was at the 25th centile and height was <3rd centile (50th centile for a 10-year-old). Head was normocephalic (25-50th centile). He had a long face with bitemporal narrowing, midface hypoplasia, downslanting palpebral fissures, bilateral epicanthal folds, and ptosis. He had normal distribution of hair with normal anterior and posterior hairlines. Ears were low-set and posteriorly rotated. He had a smooth philtrum and full lips. He had a surgically intact, but high-arched palate. Neck was short and notable for a well-healed tracheostomy scar. Chest was well-formed and without pectus deformity. Cardiovascular and pulmonary exams were normal, and abdomen was benign. He had a short trunk with scoliosis of the thoracic region, which had been surgically treated. Hands and feet were small (total hand length <<3rd centile bilaterally, 50th centile for a 10-year-old; foot length <<3rd centile bilaterally, 50th centile for a 11-year-old). Camptodactyly was noted at the DIP joint of both fifth fingers. Decreased skin creases were also noted at the DIP joint of all digits on both hands (Figure 2a Cleft palate correction was performed at age 2 years. Gold weights were placed bilaterally for treatment of lagophthalmos at age 5 years. Scoliosis surgery was performed at age 12 years. Currently she receives ventilatory support with oxygen supplementation at night. She had no history of MH.
On exam, at 16 years 5 months, head circumference was at the 3rd-10th centile, weight was <3rd centile (50th centile for a 12-year-old), and length was <<3rd centile (50th centile for a 10-year-old). Her head was brachycephalic. She had a long face with bitemporal narrowing, The samples received included whole blood for the proband in Family 1 as well as whole blood from all participating family members in Family 2. Saliva samples were obtained from family members of proband 1 including the parents, the affected 18-year-old sister, and three unaffected brothers. Genomic DNA was purified from fresh whole blood using the Gentra Puregene Kit (Qiagen Sciences, Germantown, MD). Genomic DNA from saliva samples was purified using the Gentra Puregene kit (Qiagen Sciences). Whole genome SNP genotyping was performed using the Affymetrix Genome Wide Human SNP Nsp/Sty 6.0 array (Affymetrix, Inc., Santa Clara, CA) for Family 1 members.
For Family 1, we performed WES on DNA from the proband, her 18-year-old affected sister and one of their unaffected brothers using the Agilent SureSelect Human All Exon 50Mb Kit (Agilent Technologies, Santa Clara, CA) and paired end 100 bp reads using the Illumina HiSeq2000 platform (Illumina, Inc. San Diego, CA). Read alignment to the reference genome (NCBI human genome assembly build 36; Ensembl core database release 50_361) (Hubbard et al., 2009 ) was performed using the Burrows-Wheeler Alignment (BWA) tool (Li & Durbin, 2009) , and single nucleotide variants (SNVs) and small insertion/deletions (indels) were identified using SAMtools (Li et al., 2009 ). PCR duplicates were removed using the Picard software. We also performed local realignment and base call quality recalibration using GATK (McKenna et al., 2010) .
Using the PhenoDB Variant Analysis Tool (Sobreira et al., 2015) , we analyzed the WES data by applying a filter designed to prioritize rare (Minor Allele Frequency <1%) functional variants (missense, nonsense, splice site variants, and indels) that were homozygous or compound heterozygous in the proband and the affected sister but absent or heterozygous in the unaffected brother. We excluded variants found in dbSNP 126, 129 or 131, and variants with a MAF >1% in the Exome Variant Server and the 1000 Genome Project. We Alignment and variant calling was completed using an in-house GATK-based pipeline (Linderman et al., 2014) . Patients with NAM are at relatively high risk for MH if exposed to triggering anesthesia and have a mortality rate of 21% during the newborn period and an overall 36% mortality rate during adulthood, largely attributable to MH . Individuals with NAM have normal CK levels Stewart, Kahler, & Gilchrist, 1988) , but there is conflicting data about their EMGs and muscle biopsy findings. Stewart et al. (1988) showed that EMGs in five of their NAM patients revealed evidence of myopathy, whereas muscle biopsy revealed either nonspecific myopathy or was normal (Stewart et al., 1988) . However, Stamm et al. (2008a) reported normal EMGs in three patients with NAM and widespread myopathy in a fourth. The proband in Family 1 has not had a muscle biopsy and unfortunately reports from her older sister in early childhood are not available. Neither had an EMG or CK level.
The proband and affected sister in family 2 have had normal CK levels; neither affected sibling has had an EMG.
The SH3 domain and cysteine rich (C1) domain 3 (STAC3) gene is the third member of the STAC gene family. SH3 domain and the C1 functional domains are frequently components of signaling proteins (Reinholt, Ge, Cong, Gerrard, & Jiang, 2013) Muscle contraction requires a series of events known as excitation-contraction (EC) coupling to regulate Ca2+ release from internal stores to initiate muscle contraction. STAC3 product participates in EC coupling machinery (Horstick et al., 2013; Nelson et al., 2013) . EC coupling involves a complex of proteins that include dihydropyridine receptor (DHPR) and ryanodine receptor 1 (RyR1), two Ca 2+ channels among many other components. Although STAC3 is required for voltage-induced Ca 2+ release in skeletal muscle, there may still be unknown proteins that are required for this process with which STAC3 might interact (Nelson et al., 2013) .
Recently several animal models were employed to ascertain the role of Stac3. Though different mechanisms are proposed, all agree Stac3 is essential for functional skeletal muscle. Bower et al. (2012) used morpholino knockdown studies in zebrafish embryos and RNAi in cultured C2C12 mouse myoblasts and reported that Stac3 is required for myotube formation and differentiation of skeletal myoblasts in zebrafish (Bower et al., 2012) . Reinholt et al. (2013) reported that the homozygous deletion of Stac3 in mice produced either a lethal skeletal muscle phenotype or mice which had an abnormal body curvature and dropping forelimbs and did not respond to prodding. They found Stac3 was expressed only in the skeletal muscle but was not expressed or expressed at very low levels in brain, heart, and the smooth musclecontaining stomach. Reinholt et al. (2013) hypothesized that Stac3 gene pathogenic variants disrupted myofiber maturation and may be involved in the translocation of myonuclei during skeletal muscle development (Reinholt et al., 2013) .
In contrast, Nelson et al. (2013) and muscle strength, muscle composition, and muscle contraction (Cong et al., 2016) .
In summary, our report of molecularly confirmed NAM in families from ancestries other than the Lumbee tribe of Native Americans, together with the reported Turkish case (Grzybowski et al., 2017) , highlights the need to consider NAM in the differential diagnosis of congenital myopathy in patients of all ethnicities. Of note, the Qatari sisters were noted to be homozygous for the same variant, STAC3 p.
Trp284Ser, identified in the Lumbee tribe, and the Puerto Rican siblings were compound heterozygous for STAC3 variants, with one variant also being this same change. But our data shows that this is not a common founder case since the p.Trp284Ser variant in these two families is not in the same haplotype (data not shown). Despite the clinical overlap between NAM, CFZS, and MBS, they have important differences, and STAC3 mutations were not identified in a large cohort of MBS or CFZS. Ophthalmological examination should distinguish the ptosis without significant ophthalmoplegia found in NAM and possibly CFZS from the abduction deficit that together with facial weakness defines MBS (Table 1) . Electrophysiology, brain and muscle imaging studies can help exclude a primary defect in cranial nerve development typical of MBS and narrow the diagnosis. Moreover, the presence of MH is one distinctive feature that supports a diagnosis of NAM, and STAC3 gene sequencing should be recommended to confirm this diagnosis. Additionally, early diagnosis of NAM is especially helpful for anticipatory management of MH.
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